BackgroundThe dysregulation of microRNAs (miRNAs) is associated with the pathogenesis of non-small cell lung cancer (NSCLC). However, the mechanism underlying miR-182-5p regulation of NSCLC progression is largely unknown. The purpose of this study was to examine the expression levels of miR-182-5p in human NSCLC and its funvtion in lung cancer cells. MethodsThe Cancer Genome Atlas (TCGA) data set was utilized to investigate the association between miR-182-5p expression and the clinicopathological characteristics and prognosis of NSCLC patients. The target genes of miR-182-5p were identified using the prediction tools PITA, miRmap, microT, miRanda, PicTar, and TargetScan. Transwell assays was used to explore the potential function of miR-182-5p in lung cancer cells. Luciferase reporter assay were performed to analyze the regulation of putative target of miR-182-5p and western blot assays were used to validate the luciferase results.ResultsmiR-182-5p was upregulated in NSCLC tissues and acted as an independent prognostic factor of tumor recurrence in NSCLC patients. Functionally, overexpression of miR-182-5p promoted lung cancer cell migration and invasion. Genome-wide gene expression analysis and luciferase report assay revealed that Endothelial PAS Domain-containing protein 1 (EPAS1) was a direct target of miR-182-5p. EPAS1 exhibited a negative correlation with miR-182-5p expression in NSCLC tissues. Univariate and multivariate survival analysis identified EPAS1 as an independent prognostic factor for overall survival and tumor recurrence in NSCLCConclusionsThese findings demonstrate that miR-182-5p functions as a tumor promoter in NSCLC progression by targeting EPAS1. It is, therefore, a potential indicator of tumor recurrence in NSCLC patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.